1.
S1 Dataset -
2.
3.
4.
Differences in patient characteristics and process measures.
Secondary treatment effects and study setting interaction effects.
Real-Life Study of Mepolizumab in Idiopathic Chronic Eosinophilic Pneumonia.
Services, Inequality, and the Dutch Disease
Supporting information I–materials.
Supporting information II–results.
Supporting information III–codebook.
The study’s timeline, including the times of measurement and the relevant events surrounding the pandemic.
Code clusters.